Beam Therapeutics Inc (BEAM)

NASDAQ · Biotechnology

26.34
-0.76 (-2.80%)
Updated Aug 18, 5:00 PM ET
AI Rating
Hold
Overall Score
41
Trend
28
Momentum
51
Risk
46

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Feb 24, 2026 120 sessions Aug 14, 2026

AI Analysis

Beam Therapeutics Inc is trading at $26.34, down 2.80% on the session. The 50 day average sits at $30.12 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 43.6, which reads as weak, and MACD is bullish crossover. Volume is below average.

The nearest support is around $24.67 with resistance near $27.02, so that band frames the current range. Average daily movement is roughly $1.57, or about 6.0% of the share price, which is what any stop placement has to allow for. The overall health score of 41 out of 100 combines a trend score of 28, momentum of 51 and a risk score of 46.

Technical indicators

RSI (14)
43.6
weak
MACD
-0.911
bullish crossover
SMA 20
26.54
SMA 50
30.12
SMA 200
--
unknown
ATR (14)
1.57
avg daily range
Support
24.67
Resistance
27.02
Volume vs 20d
0.70x
below average
Volatility
52.4%
annualised
1 month
-5.78%
3 months
-9.41%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.